Anand Kawade

Long-term impact of a reduced two-dose (1p+1) schedule of 10- and 13-valent pneumococcal conjugate vaccines (Synflorix and Prevenar13)) on nasopharyngeal carriage in rural Indian children: A prospective cohort study

Anand Kawade, Aditi Apte, Girish Dayma, Nilima Telang et autres

in (code pays fourni par la source)

Immunogenicity of Neonatal versus Infant Schedules of Rotavirus Vaccines in India: Study Protocol for a Phase IV Randomized Controlled Trial

Girish Dayma, Anand Kawade, Aditi Apte, Tintu Varghese et autres

in (code pays fourni par la source)

Immunogenicity and safety of an inactivated split-virion influenza vaccine in individuals 6 months of age and older in India

Pedro M. Folegatti, Cynthia Tabar, Céline Petit, Parth Vachhani et autres

in, it, us (code pays fourni par la source)

Immunogenicity and safety of an inactivated split-virion influenza vaccine in individuals 6 months of age and older in India

Pedro M. Folegatti, Cynthia Tabar, Céline Petit, Parth Vachhani et autres

Immunogenicity and safety of an inactivated split-virion influenza vaccine in individuals 6 months of age and older in India

Pedro M. Folegatti, Cynthia Tabar, Céline Petit, Parth Vachhani et autres

Immunogenicity and safety of Biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trial

Subhash Thuluva, Ramesh V. Matur, SubbaReddy Gunneri, Siddalingaiah Ningaiah et autres

in (code pays fourni par la source)

The ProSPoNS Trial: Statistical Analysis Protocol for Evaluating Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0–2-month-old Low Birth Weight Infants in India

Dilip Raja, Kamaleshwar S Mahajan, Anju Sinha, Subodh S. Gupta et autres

in (code pays fourni par la source)

Immunogenicity and Safety of Biological E’s 14-Valent Pneumococcal Conjugate Vaccine (PNEUBEVAX 14 ® ) Administered in a 2p+1 Schedule to Healthy Infants: A Multicenter, Randomized, Active Controlled, Single-Blind, Phase III Trial

Subhash Thuluva, Ramesh V. Matur, SubbaReddy Gunneri, Siddalingaiah Ningaiah et autres

in (code pays fourni par la source)

The impact of maternal influenza vaccination on reducing morbidity in postpartum mothers and their infants: A prospective cohort study

Hanif Shaikh, Pranesha Koli, Anil Pardeshi, Parveen Shaikh et autres

kr, in (code pays fourni par la source)

Long-term impact of a reduced two-dose (1p+1) schedule of 10- and 13-valent pneumococcal conjugate vaccines (Synflorix and Prevenar13)) on nasopharyngeal carriage in rural Indian children: A prospective cohort study

Anand Kawade, Aditi Apte, Girish Dayma, Nilima Telang et autres

in (code pays fourni par la source)

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study

Prasad S. Kulkarni, Anand Kawade, Sunil Kohli, Renuka Munshi et autres

in, us, ca (code pays fourni par la source)

A randomized, active-controlled, multi-centric, phase-II clinical study to assess safety and immunogenicity of a fully liquid DTwP-HepB-IPV-Hib hexavalent vaccine (HEXASIIL®) in Indian toddlers

Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale et autres

in (code pays fourni par la source)